Chronic myelomonocytic leukemia with ring sideroblasts/SF3B1 mutation presents with low monocyte count and resembles myelodysplastic syndromes with-RS/SF3B1 mutation in terms of phenotype and prognosis Front Oncol
A SIRT7-dependent acetylation switch regulates early B cell differentiation and lineage commitment through Pax5 NAT IMMUNOL
The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models Genome Med
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023 Hematol Oncol
NF-κB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment Sci Adv
Targeting RNA modifications in leukaemia: Epitranscriptomic drugs are the new kids on the block BRIT J HAEMATOL